Johnson & Johnson Innovative Medicine Archives

Bladder Cancer Risk Factors and Prevalence

Anne E. Lizardi, DNP, CRNP, RNFA, reviews bladder cancer prevalence and key modifiable risk factors for clinicians.

Anne E. Lizardi, DNP, CRNP, RNFA, reviews current guideline-based bladder cancer management, from intravesical therapy to systemic approaches.

Anne E. Lizardi, DNP, CRNP, RNFA, details bladder cancer evaluation, cystoscopy, biomarkers, and imaging for diagnosis and staging.

Anne E. Lizardi, DNP, RNFA, provides a concise overview of the evolving prostate cancer treatment landscape.

Anne E. Lizardi, DNP, CRNP, RNFA, presents an overview of prostate cancer prevalence and associated risk factors.